Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2089 of 6351
-
Artificial intelligence reads brain scans to detect deadly tumors
Diagnosis CompletedThe goal of this observational study is to learn whether an artificial intelligence system called GliomaAI-MG can help detect a specific molecular type of brain tumour called molecular glioblastoma using routine MRI scans. The study uses previously collected and fully anonymised …
Sponsor: Deep Learning Institute of Radiological Sciences • Aim: Diagnosis
Last updated Jun 27, 2026 14:02 UTC
-
Could an old HIV drug beat kaposi sarcoma?
Disease control CompletedThis pilot phase II trial studies how well nelfinavir mesylate works in treating patients with kaposi sarcoma. Nelfinavir mesylate may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
Phase 2 • Sponsor: AIDS Malignancy Consortium • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Scientists hunt for hidden genes behind rare diseases
Knowledge-focused Recruiting nowRare diseases are conditions affecting a small number of people, requiring specific and often multidisciplinary medical care. There are over 7,000 rare diseases, around 80% of which are genetic in origin. These diseases are generally severe, chronic and progressive, and can consi…
Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:02 UTC
-
New drug targets rare genetic glitch in advanced cancers
Disease control OngoingThis phase II MATCH treatment trial tests how well MLN0128 (TAK-228) works in treating patients with cancer that has certain genetic changes called mTOR mutations. MLN0128 (TAK-228) may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth.
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New drug targets rare cancer mutations in phase II trial
Disease control OngoingThis phase II MATCH treatment trial tests how well MLN0128 (TAK-228) works in treating patients with cancer that has certain genetic changes called TSC1 or TSC2 mutations. MLN0128 (TAK-228) may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New heart device aims to ease heart failure symptoms
Disease control OngoingThis is a post market trial to be conducted at sites in Germany. The device has CE approval in the EU. The purpose of this observational registry is to collect post market data in consecutive patients treated with the IASD System II, to further evaluate efficacy, safety and quali…
Sponsor: Corvia Medical • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Could a blood flow drug strengthen pelvic muscles to curb incontinence?
Disease control OngoingThe investigators goal is to develop medical treatments for stress/mixed urinary incontinence. Sildenafil has been shown to improve blood flow as well as muscle mass and strength and to decrease muscle fatigue. The investigators believe that it will improve muscular atrophy in th…
Phase 1 • Sponsor: The University of Texas Medical Branch, Galveston • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Can we optimize antibiotic dosing for children with sepsis?
Knowledge-focused CompletedMortality benefit has been proven with early antibiotic administration in sepsis. Antimicrobial therapy should be based on early achievement of effective drug concentrations by optimizing the pharmacokinetic/pharmacodynamics of individual drugs. Optimal dosing in the critically i…
Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago • Aim: Knowledge-focused
Last updated Aug 16, 2026 00:00 UTC
-
Supercharged immune cells take on Hard-to-Treat prostate cancer
Disease control OngoingThis is a single center, single arm Phase I study to establish the safety and feasibility of intravenously administered lentivirally transduced dual PSMA-specific/TGFβ-resistant CAR modified autologous T cells (CART-PSMA-TGFβRDN cells) in patients with metastatic castrate resista…
Phase 1 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Immunotherapy and chemo join forces against tough lymphoma
Disease control Recruiting nowThis randomized phase I/II trial studies the best dose and side effects of durvalumab and to see how well it works with or without lenalidomide in treating patients with cutaneous or peripheral T cell lymphoma that has come back and does not respond to treatment. Monoclonal antib…
Phase 1/2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Tech tool boosts asthma care for city kids
Disease control CompletedThe overall goal of this research study is to test the effectiveness of a multifaceted and multi-level prompting intervention in a real world urban primary care office setting on improving provider-delivered guideline-based asthma care and reducing asthma morbidity among urban ch…
Sponsor: Montefiore Medical Center • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New vaccine combo aims to halt early myeloma
Disease control OngoingThis research study is studying a targeted therapy as a possible treatment for Smoldering Multiple Myeloma. The following intervention will be involved in this study: * Lenalidomide * Citarinostat (CC-96241) * PVX-410
Phase 1 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Immunotherapy combo shows promise for bladder cancer patients unable to get chemo
Disease control OngoingThis pilot phase I trial studies the side effects of durvalumab and tremelimumab in treating patients with muscle-invasive, high-risk urothelial cancer that cannot be treated with cisplatin-based therapy before surgery. Immunotherapy with monoclonal antibodies, such as durvalumab…
Early phase 1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Prostate cancer radiation showdown: which implant works best?
Disease control OngoingThe purpose of this study is to evaluate the dose of High Dose Rate (HDR) brachytherapy chosen for this study as well as a commonly used alternate form of brachytherapy called low dose rate (or seed) brachytherapy. Investigators would like to understand how these treatments contr…
Sponsor: Canadian Cancer Trials Group • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New daily pill shows promise for spinal muscular atrophy
Disease control CompletedThis is a multi-center, exploratory, non-comparative, and open-label study to investigate the safety, tolerability, PK, and PK/PD relationship of risdiplam in adults, children and infants with Spinal Muscular Atrophy (SMA) previously enrolled in Study BP29420 (Moonfish) with the …
Phase 2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Parkinson's pump trial aims to keep Early-Stage patients on their feet
Symptom relief CompletedThe aim of the study is to assess the use of the apomorphine pump in earlier stages of Parkinson' Disease (PD), when motor complications have just developed and before patients are significantly affected in their social and occupational functioning. The investigators hypothesize …
Phase 3 • Sponsor: Rennes University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Heart pacing during surgery may predict and prevent Post-Op AFib
Prevention Recruiting nowPatients undergoing first time cardiac surgery will undergo rapid atrial pacing prior to initiation of cardiopulmonary bypass to screen for AF inducibility. Patients with inducible AF will be randomized to prophylactic amiodarone treatment versus no treatment. Patients who are no…
Phase 4 • Sponsor: Stanford University • Aim: Prevention
Last updated Jun 27, 2026 09:05 UTC
-
Kids' garden program could sow seeds for healthier futures
Prevention CompletedThe objective of this study is to implement and test the efficacy of the "Summer Harvest Adventure," a comprehensive garden-based behavioral, social, and environmental intervention for children (ages 8-11 years) residing in low-resource communities.
Sponsor: Ohio State University • Aim: Prevention
Last updated Jul 02, 2026 00:00 UTC
-
Robot or scalpel? new study tests best bladder cancer surgery
Disease control CompletedThis is a prospective multicentre randomised controlled trial comparing the outcomes from Intracorporeal RARC (iRARC) with open radical cystectomy (ORC) in patients with bladder cancer. The study will recruit patients with non-muscle invasive bladder cancer (NMIBC) or muscle inva…
Sponsor: University College, London • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Could a simple recovery checklist slash hospital stays after colorectal surgery?
Knowledge-focused Recruiting nowThis is an observational study to look at the impact of the Enhanced Recovery After Surgery system for colorectal surgery (Group 1) in shortening hospital length of stay, reducing postoperative narcotic consumption, lowering Visual Analog Scale scores, decreasing the incidence of…
Sponsor: University of Arkansas • Aim: Knowledge-focused
Last updated Aug 07, 2026 00:00 UTC